NCT00705367View on ClinicalTrials.gov

Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

July 31, 2011

Conditions
Lupus Nephritis
Interventions
DRUG

Placebo

Infusion, Intravenous, single dose, Day 1

DRUG

Abatacept

Infusion, Intravenous, 30mg/kg, single dose, Day 1

DRUG

Abatacept

Infusion, intravenous, 10 mg/kg, administered on Days 15 and 29 followed by doses every 4 weeks until the end of the study

Trial Locations (1)

200001

Local Institution, Shanghai

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00705367 - Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg | Biotech Hunter | Biotech Hunter